Evidence map›Paper›PMID 41462911›Full record

ArticleBiomedicines2025

Potential Regulatory Role of miR-15b, miR-99b, and miR-181a of the Shikonin-Induced MAPK/ERK Apoptotic Signaling Pathway in Renal Carcinoma.

Anna Vass, József Király, Erzsébet Szabó, Nitya Shree, Deisy Ramos, Mahua Choudhury, Petra Fodor, Krisztián Szegedi, Gábor Halmos, Zsuzsanna Szabó

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna VassDepartment of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.
József KirályDepartment of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.
Erzsébet SzabóDepartment of Pharmacology, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.
Nitya ShreeDepartment of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M Health Science Center, College Station, TX 77845, USA.
Deisy RamosDepartment of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M Health Science Center, College Station, TX 77845, USA.
Mahua ChoudhuryDepartment of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M Health Science Center, College Station, TX 77845, USA.
Petra FodorDepartment of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.
Krisztián SzegediDepartment of Urology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.ORCID 0000-0003-4311-9936
Gábor HalmosDepartment of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.
Zsuzsanna SzabóDepartment of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.

Funding

GINOP-2.3.2-15-2016-00043 GINOP-2.3.2-15-2016-00043TKP2021-EGA-20 TKP2021-EGA-20
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

A-498apoptosisCAKI-2miR-15bmiR-181amiR-99brenal cell carcinomashikoninspecific target

Identifiers

PMID41462911
PMCPMC12730689

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.